Grueninger; Fiona

Patent Applications and Registrations

Patent applications and USPTO patent grants for Grueninger; Fiona.The latest application filed is for "humanized anti-tau(ps422) antibodies and methods of use".

Company Profile

7.12.16

Grueninger; Fiona - Arlesheim CH
- Arlesheim CH

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Camelid single-domain antibody directed against phosphorylated tau proteins and methods for producing conjugates thereof Grant 11,124,563 - Lafaye , et al. September 21, 2	2021-09-21
Humanized Anti-tau(ps422) Antibodies And Methods Of Use App 20210139571 - Dengl; Stefan ; et al.	2021-05-13
Humanized anti-tau(pS422) antibodies and methods of use Grant 10,822,402 - Dengl , et al. November 3, 2	2020-11-03
Oligopeptide and methods for producing conjugates thereof Grant 10,787,505 - Lafaye , et al. September 29, 2	2020-09-29
Humanized Anti-tau(ps422) Antibodies And Methods Of Use App 20200223912 - Grueninger; Fiona ; et al.	2020-07-16
Camelid Single-domain Antibody Directed Against Phosphorylated Tau Proteins And Methods For Producing Conjugates Thereof App 20200165329 - LAFAYE; Pierre ; et al.	2020-05-28
Camelid single-domain antibody directed against phosphorylated tau proteins and methods for producing conjugates thereof Grant 10,538,582 - Lafaye , et al. Ja	2020-01-21
Humanized anti-Tau(pS422) antibodies and methods of use Grant 10,465,000 - Grueninger , et al. No	2019-11-05
Humanized anti-Tau(pS422) antibodies and methods of use Grant 10308710 -	2019-06-04
Camelid Single-domain Antibody Directed Against Phosphorylated Tau Proteins And Methods For Producing Conjugates Thereof App 20190077853 - Lafaye; Pierre ; et al.	2019-03-14
Camelid single-domain antibody directed against phosphorylated tau proteins and methods for producing conjugates thereof Grant 10,087,245 - Lafaye , et al. October 2, 2	2018-10-02
Humanized Anti-tau(ps422) Antibodies And Methods Of Use App 20180079804 - Dengl; Stefan ; et al.	2018-03-22
Humanized anti-tau(pS422) antibodies and methods of use Grant 9,862,763 - Dengl , et al. January 9, 2	2018-01-09
Camelid single-domain antibody directed against amyloid beta and methods for producing conjugates thereof Grant 9,738,712 - Lafaye , et al. August 22, 2	2017-08-22
HUMANIZED ANTI-Tau(pS422) ANTIBODIES AND METHODS OF USE App 20170129949 - Grueninger; Fiona ; et al.	2017-05-11
Camelid Single-domain Antibody Directed Against Phosphorylated Tau Proteins And Methods For Producing Conjugates Thereof App 20170058022 - LAFAYE; Pierre ; et al.	2017-03-02
Humanized anti-Tau(pS422) antibodies and methods of use Grant 9,562,091 - Grueninger , et al. February 7, 2	2017-02-07
HUMANIZED ANTI-TAU(pS422) ANTIBODIES AND METHODS OF USE App 20160376352 - Dengl; Stefan ; et al.	2016-12-29
Oligopeptide And Methods For Producing Conjugates Thereof App 20160355575 - LAFAYE; Pierre ; et al.	2016-12-08
Camelid Single-domain Antibody Directed Against Amyloid Beta And Methods For Producing Conjugates Thereof App 20160347831 - LAFAYE; Pierre ; et al.	2016-12-01
Use of an anti-Tau pS422 antibody for the treatment of brain diseases Grant 9,290,567 - Bohrmann , et al. March 22, 2	2016-03-22
HUMANIZED ANTI-Tau(pS422) ANTIBODIES AND METHODS OF USE App 20150175685 - Grueninger; Fiona ; et al.	2015-06-25
Method For The Identification Of Beta-sheet Aggregated Protein Ligands App 20140363898 - Borroni; Edilio ; et al.	2014-12-11
Use of an anti-Tau pS422 antibody for the treatment of brain diseases Grant 8,609,097 - Bohrmann , et al. December 17, 2	2013-12-17
Use Of An Anti-tau Ps422 Antibody For The Treatment Of Brain Diseases App 20130310541 - Bohrmann; Bernd ; et al.	2013-11-21
Use Of An Anti-tau Ps422 Antibody For The Treatment Of Brain Diseases App 20110059093 - Bohrmann; Bernd ; et al.	2011-03-10
Antibody that recognizes phosphorylated peptides App 20070280935 - Bohrmann; Bernd ; et al.	2007-12-06
Assay for identifying beta secretase inhibitors App 20030125257 - Brockhaus, Manfred ; et al.	2003-07-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.